Reduction in audit burden: By replacing individual audits from pharmaceutical companies with a few thorough and broadly shared audits, suppliers are able to reduce the cost and burden of audits.

Reduction in administrative costs: Using a standardized consortium pre-audit questionnaire, quality agreements and certificates of analysis significantly reduces administrative burdens, making automation simpler and faster, and thus reducing overall costs.

“Rx-360 is a one-stop venue for understanding the issues, solutions, and emerging regulations around the pharmaceutical supply chain. AbbVie’s participation allows our shared service audit team to apply enhanced focus and risk prevention with critical suppliers.”

Wes Schmidt
Divisional Vice President, Operations Quality Assurance, AbbVie

Eligibility Rules >>


  • Ajinomoto Co., Inc
  • Althea
  • AMPAC Fine Chemicals, Member Since 2011
  • Asahi Kasei
  • Aurisco
  • Avantor Inc.
  • BASF Corporation, Member Since 2009
  • DSM Nutritional Products Ltd., Member Since 2011
  • Excella GmbH, Member Since 2015
  • FUJIFILM Diosynth Biotechnologies, Member Since 2013
  • GE Healthcare Bio-Sciences, Member Since 2009
  • Hikal Ltd, Member Since 2010
  • Hovione, Member Since 2009
  • Imperial Health Sciences, Member Since 2016
  • Jiangsu Hansyn
  • LifeConEx, Member Since 2010
  • Ligand Pharmaceuticals, Inc, Member Since 2012
  • Merck KGaA, Member Since 2009
  • Millipore Sigma
  • Neuland Laboratories
  • OSO BioPharmaceuticals
  • Sartorius AG, Member Since 2012
  • Sparta Systems Inc, Member Since 2015
  • Thermo Fisher
  • Unisys
  • VWR International, Member Since 2009
  • West, Member Since 2009